 | • レポートコード：GIR-2104Z02688 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、犬インフルエンザ治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。犬インフルエンザ治療の種類別市場規模（ワクチン、その他）、用途別市場規模（獣医診療所、獣医病院、動物医療施設）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・犬インフルエンザ治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck & Co、Intervet、Zoetis Services ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ワクチン、その他 ・用途別分析2016年-2026年：獣医診療所、獣医病院、動物医療施設 ・犬インフルエンザ治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・犬インフルエンザ治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・犬インフルエンザ治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・犬インフルエンザ治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・犬インフルエンザ治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Canine Flu Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Canine Flu Therapeutics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Canine Flu Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Canine Flu Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Vaccines
Others
Market segment by Application, can be divided into
Vet Clinics
Veterinary Hospitals
Animal Healthcare Facilities
Market segment by players, this report covers
Merck & Co
Intervet
Zoetis Services
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Canine Flu Therapeutics
1.2 Classification of Canine Flu Therapeutics by Type
1.2.1 Overview: Global Canine Flu Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Canine Flu Therapeutics Revenue Market Share by Type in 2020
1.2.3 Vaccines
1.2.4 Others
1.3 Global Canine Flu Therapeutics Market by Application
1.3.1 Overview: Global Canine Flu Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Vet Clinics
1.3.3 Veterinary Hospitals
1.3.4 Animal Healthcare Facilities
1.4 Global Canine Flu Therapeutics Market Size & Forecast
1.5 Global Canine Flu Therapeutics Market Size and Forecast by Region
1.5.1 Global Canine Flu Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Canine Flu Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Canine Flu Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Canine Flu Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Canine Flu Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Canine Flu Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Canine Flu Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Canine Flu Therapeutics Market Drivers
1.6.2 Canine Flu Therapeutics Market Restraints
1.6.3 Canine Flu Therapeutics Trends Analysis
2 Company Profiles
2.1 Merck & Co
2.1.1 Merck & Co Details
2.1.2 Merck & Co Major Business
2.1.3 Merck & Co Canine Flu Therapeutics Product and Solutions
2.1.4 Merck & Co Canine Flu Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Merck & Co Recent Developments and Future Plans
2.2 Intervet
2.2.1 Intervet Details
2.2.2 Intervet Major Business
2.2.3 Intervet Canine Flu Therapeutics Product and Solutions
2.2.4 Intervet Canine Flu Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Intervet Recent Developments and Future Plans
2.3 Zoetis Services
2.3.1 Zoetis Services Details
2.3.2 Zoetis Services Major Business
2.3.3 Zoetis Services Canine Flu Therapeutics Product and Solutions
2.3.4 Zoetis Services Canine Flu Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Zoetis Services Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Canine Flu Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Canine Flu Therapeutics Players Market Share
3.2.2 Top 10 Canine Flu Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Canine Flu Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Canine Flu Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Canine Flu Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Canine Flu Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Canine Flu Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Canine Flu Therapeutics Revenue by Type (2016-2026)
6.2 North America Canine Flu Therapeutics Revenue by Application (2016-2026)
6.3 North America Canine Flu Therapeutics Market Size by Country
6.3.1 North America Canine Flu Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Canine Flu Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Canine Flu Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Canine Flu Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Canine Flu Therapeutics Revenue by Type (2016-2026)
7.2 Europe Canine Flu Therapeutics Revenue by Application (2016-2026)
7.3 Europe Canine Flu Therapeutics Market Size by Country
7.3.1 Europe Canine Flu Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Canine Flu Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Canine Flu Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Canine Flu Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Canine Flu Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Canine Flu Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Canine Flu Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Canine Flu Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Canine Flu Therapeutics Market Size by Region
8.3.1 Asia-Pacific Canine Flu Therapeutics Revenue by Region (2016-2026)
8.3.2 China Canine Flu Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Canine Flu Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Canine Flu Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Canine Flu Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Canine Flu Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Canine Flu Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Canine Flu Therapeutics Revenue by Type (2016-2026)
9.2 South America Canine Flu Therapeutics Revenue by Application (2016-2026)
9.3 South America Canine Flu Therapeutics Market Size by Country
9.3.1 South America Canine Flu Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Canine Flu Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Canine Flu Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Canine Flu Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Canine Flu Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Canine Flu Therapeutics Market Size by Country
10.3.1 Middle East & Africa Canine Flu Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Canine Flu Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Canine Flu Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Canine Flu Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Canine Flu Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Canine Flu Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Canine Flu Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Canine Flu Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Canine Flu Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Merck & Co Corporate Information, Head Office, and Major Competitors
Table 7. Merck & Co Major Business
Table 8. Merck & Co Canine Flu Therapeutics Product and Solutions
Table 9. Merck & Co Canine Flu Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Intervet Corporate Information, Head Office, and Major Competitors
Table 11. Intervet Major Business
Table 12. Intervet Canine Flu Therapeutics Product and Solutions
Table 13. Intervet Canine Flu Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Zoetis Services Corporate Information, Head Office, and Major Competitors
Table 15. Zoetis Services Major Business
Table 16. Zoetis Services Canine Flu Therapeutics Product and Solutions
Table 17. Zoetis Services Canine Flu Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Global Canine Flu Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 19. Global Canine Flu Therapeutics Revenue Share by Players (2019-2021)
Table 20. Breakdown of Canine Flu Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 21. Canine Flu Therapeutics Players Head Office, Products and Services Provided
Table 22. Canine Flu Therapeutics Mergers & Acquisitions in the Past Five Years
Table 23. Canine Flu Therapeutics New Entrants and Expansion Plans
Table 24. Global Canine Flu Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 25. Global Canine Flu Therapeutics Revenue Share by Type (2016-2021)
Table 26. Global Canine Flu Therapeutics Revenue Forecast by Type (2021-2026)
Table 27. Global Canine Flu Therapeutics Revenue by Application (2016-2021)
Table 28. Global Canine Flu Therapeutics Revenue Forecast by Application (2021-2026)
Table 29. North America Canine Flu Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 30. North America Canine Flu Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 31. North America Canine Flu Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 32. North America Canine Flu Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 33. North America Canine Flu Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 34. North America Canine Flu Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 35. Europe Canine Flu Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 36. Europe Canine Flu Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 37. Europe Canine Flu Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 38. Europe Canine Flu Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 39. Europe Canine Flu Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 40. Europe Canine Flu Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 41. Asia-Pacific Canine Flu Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 42. Asia-Pacific Canine Flu Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 43. Asia-Pacific Canine Flu Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 44. Asia-Pacific Canine Flu Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 45. Asia-Pacific Canine Flu Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 46. Asia-Pacific Canine Flu Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 47. South America Canine Flu Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 48. South America Canine Flu Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 49. South America Canine Flu Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 50. South America Canine Flu Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 51. South America Canine Flu Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 52. South America Canine Flu Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 53. Middle East & Africa Canine Flu Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 54. Middle East & Africa Canine Flu Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 55. Middle East & Africa Canine Flu Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 56. Middle East & Africa Canine Flu Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 57. Middle East & Africa Canine Flu Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 58. Middle East & Africa Canine Flu Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Canine Flu Therapeutics Picture
Figure 2. Global Canine Flu Therapeutics Revenue Market Share by Type in 2020
Figure 3. Vaccines
Figure 4. Others
Figure 5. Canine Flu Therapeutics Revenue Market Share by Application in 2020
Figure 6. Vet Clinics Picture
Figure 7. Veterinary Hospitals Picture
Figure 8. Animal Healthcare Facilities Picture
Figure 9. Global Canine Flu Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Canine Flu Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Canine Flu Therapeutics Revenue Market Share by Region (2016-2026)
Figure 12. Global Canine Flu Therapeutics Revenue Market Share by Region in 2020
Figure 13. North America Canine Flu Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Canine Flu Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Canine Flu Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Canine Flu Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Canine Flu Therapeutics Market Drivers
Figure 18. Canine Flu Therapeutics Market Restraints
Figure 19. Canine Flu Therapeutics Market Trends
Figure 20. Merck & Co Recent Developments and Future Plans
Figure 21. Intervet Recent Developments and Future Plans
Figure 22. Zoetis Services Recent Developments and Future Plans
Figure 24. Global Canine Flu Therapeutics Revenue Share by Players in 2020
Figure 25. Canine Flu Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 26. Global Top 3 Players Canine Flu Therapeutics Revenue Market Share in 2020
Figure 27. Global Top 10 Players Canine Flu Therapeutics Revenue Market Share in 2020
Figure 28. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 29. Global Canine Flu Therapeutics Revenue Share by Type in 2020
Figure 30. Global Canine Flu Therapeutics Market Share Forecast by Type (2021-2026)
Figure 31. Global Canine Flu Therapeutics Revenue Share by Application in 2020
Figure 32. Global Canine Flu Therapeutics Market Share Forecast by Application (2021-2026)
Figure 33. North America Canine Flu Therapeutics Sales Market Share by Type (2016-2026)
Figure 34. North America Canine Flu Therapeutics Sales Market Share by Application (2016-2026)
Figure 35. North America Canine Flu Therapeutics Revenue Market Share by Country (2016-2026)
Figure 36. United States Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. Canada Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Mexico Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Europe Canine Flu Therapeutics Sales Market Share by Type (2016-2026)
Figure 40. Europe Canine Flu Therapeutics Sales Market Share by Application (2016-2026)
Figure 41. Europe Canine Flu Therapeutics Revenue Market Share by Country (2016-2026)
Figure 42. Germany Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. France Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. United Kingdom Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Russia Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Italy Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Canine Flu Therapeutics Sales Market Share by Type (2016-2026)
Figure 48. Asia-Pacific Canine Flu Therapeutics Sales Market Share by Application (2016-2026)
Figure 49. Asia-Pacific Canine Flu Therapeutics Revenue Market Share by Region (2016-2026)
Figure 50. China Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Japan Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. South Korea Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. India Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Southeast Asia Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Australia Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South America Canine Flu Therapeutics Sales Market Share by Type (2016-2026)
Figure 57. South America Canine Flu Therapeutics Sales Market Share by Application (2016-2026)
Figure 58. South America Canine Flu Therapeutics Revenue Market Share by Country (2016-2026)
Figure 59. Brazil Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Argentina Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Middle East and Africa Canine Flu Therapeutics Sales Market Share by Type (2016-2026)
Figure 62. Middle East and Africa Canine Flu Therapeutics Sales Market Share by Application (2016-2026)
Figure 63. Middle East and Africa Canine Flu Therapeutics Revenue Market Share by Country (2016-2026)
Figure 64. Turkey Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Saudi Arabia Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. UAE Canine Flu Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Methodology
Figure 68. Research Process and Data Source
世界の犬インフルエンザ治療市場規模・現状・予測（2021年-2027年） Canine flu, which is also called dog flu; is a contagious disease that affects the dog’s respiratory system. It is mainly caused by canine influenza virus/Type An influenza virus. There are two types of influenza viruses H3N2 virus H3N8 virus. Market Analysis and Insights: Global Canine Flu Therapeu…- 世界の犬リンパ腫治療市場規模・現状・予測（2021年-2027年） Malignant lymphoma or lymphosarcoma are one of the common tumours in canine species such as dogs accounting for approximately 7-24% of all canine tumours and 83% of all canine blood cells malignancies. Canine lymphoma treatment are drugs used in the treatment and mitigation of tumours. Market Analys…
- 世界の犬リンパ腫治療市場規模・現状・予測（2021年-2027年） Malignant lymphoma or lymphosarcoma are one of the common tumours in canine species such as dogs accounting for approximately 7-24% of all canine tumours and 83% of all canine blood cells malignancies. Canine lymphoma treatment are drugs used in the treatment and mitigation of tumours. Market Analys…
- 世界の犬関節炎治療市場規模・現状・予測（2021年-2027年） The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly …
- 世界の犬関節炎治療市場規模・現状・予測（2021年-2027年） The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly …